Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty



Status:Completed
Conditions:Arthritis, Osteoarthritis (OA)
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:40 - Any
Updated:7/11/2015
Start Date:June 2009
End Date:December 2013
Contact:Todd Curry
Email:tcurry@hccrsite.com
Phone:512-638-3242

Use our guide to learn which trials are right for you!

Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial

The primary objectives of the study is to compare gait kinematics and the return to
normalization of gait in patients that have undergone a Total Hip Arthroplasty (THA) via the
direct anterior approach versus the posterior approach. Gait kinematics will be measured
using the IDEEA LifeGait device from Minisun (Fresno, CA).

This is a prospective study of two different surgical approaches to THA, direct anterior vs
posterior approach in approximately 64 patients that meet the standard criteria for the
implantation of primary total hip replacement utilizing the Medacta implants and have
elected to undergo THA.

Inclusion Criteria:

- Patients fulfilling the standard criteria for the implantation of primary total hip
arthroplasty

- Those presenting with primary or secondary osteoarthritis

- Those presenting with disease that meets the indications for use for Medacta USA
implants defined by this study (on-label use)

Exclusion Criteria:

- Pregnant women or women who plan to conceive within the year following surgery

- Inflammatory arthritic condition

- Those whose prospects for a recovery to independent mobility would be compromised by
known coexistent, medical problems

- Those already treated with a failed Total Hip Arthroplasty (THA)

- Muscle contracture around the hip joint

- Individuals who have undergone organ transplant

- Those with a known co-existent medical condition where death is anticipated within
five years due to the pre-existing medical condition.

- Those with one or more medical conditions identified as a contraindication defined by
the labeling on any Medacta implants used in this study

- Individuals who have had a THA on the contra-lateral side within the 6 months.

- Individuals who have undergone a THR on the contra-lateral side and whose outcome is
considered unsatisfactory or not good

- Individuals requiring bilateral hip replacement

- Individuals whose body mass index (BMI; kg/m2) >40

- Individuals with active or suspected infection or sepsis

- Individuals with chronic renal failure as defined by the need for dialysis

- Patients with severe forms of developmental dysplasia of the hip (DDH): Crowe types
II, III, IV

- History of drug and/or substance abuse
We found this trial at
4
sites
Fresno, California 93710
?
mi
from
Fresno, CA
Click here to add this to my saved trials
Lone Tree, Colorado 80124
?
mi
from
Lone Tree, CO
Click here to add this to my saved trials
St. George, Utah 84790
?
mi
from
St. George, UT
Click here to add this to my saved trials
Surprise, Arizona 85374
?
mi
from
Surprise, AZ
Click here to add this to my saved trials